# Vosoritide for Short Stature in Turner Syndrome

> **NCT05849389** · PHASE2 · RECRUITING · sponsor: **Roopa Kanakatti Shankar, MBBS, MS** · enrollment: 20 (estimated)

## Conditions studied

- Turner Syndrome
- Short Stature

## Interventions

- **DRUG:** Vosoritide

## Key facts

- **NCT ID:** NCT05849389
- **Lead sponsor:** Roopa Kanakatti Shankar, MBBS, MS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-12
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05849389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05849389, "Vosoritide for Short Stature in Turner Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05849389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*